FASN and hepatocellular carcinoma: FASN is a rate-limiting enzyme complex that catalyzes de novo lipogenesis, and its level is frequently increased in human hepatocellular carcinoma, which is accompanied by diminished FASN acetylation and is conducive to tumor cell growth [206].